Literature DB >> 3347367

Systemic administration of naloxone produces analgesia in BALB/c mice in the formalin pain test.

A L Vaccarino1, R A Tasker, R Melzack.   

Abstract

Systemic administration of naloxone usually produces either hyperalgesia or no change in nociception depending on the animal species used and/or the pain test employed. This study, however, demonstrates that naloxone produces a dose-dependent analgesia in the formalin pain test using an inbred strain of albino mouse. Female BALB/c, C57BL/6 and CD1 mice were injected subcutaneously with naloxone HCl in saline (0.1 10.0 mg/kg) or saline alone, and tested for analgesia using the formalin test. Naloxone produced a statistically significant dose-dependent analgesia in the BALB/c mice, with an ED50 of 0.24 mg/kg and almost total analgesia at doses of 1 mg/kg or greater. No changes in pain behaviour were observed in the C57BL/6 or CD1 strains of mice. We believe this to be the first report of analgesia following administration of doses of naloxone normally used for opioid antagonism. To determine if this effect was specific to the formalin test, the 3 strains of mice were injected subcutaneously with naloxone HCl and tested in the tail-flick test. Naloxone had no analgesic action in this test in any of the strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347367     DOI: 10.1016/0304-3940(88)90345-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  The genetic mediation of individual differences in sensitivity to pain and its inhibition.

Authors:  J S Mogil
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults.

Authors:  Christopher R France; Mustafa al'Absi; Christopher Ring; Janis L France; Angie Harju; Lorentz E Wittmers
Journal:  Biol Psychol       Date:  2006-12-27       Impact factor: 3.251

Review 3.  The genetics of pain and pain inhibition.

Authors:  J S Mogil; W F Sternberg; P Marek; B Sadowski; J K Belknap; J C Liebeskind
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

4.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.

Authors:  Cruz M Cendán; José M Pujalte; Enrique Portillo-Salido; José M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Standardization of the rat paw formalin test for the evaluation of analgesics.

Authors:  H Wheeler-Aceto; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

Authors:  Linda M Rorick-Kehn; Jennifer W Witcher; Stephen L Lowe; Celedon R Gonzales; Mary Ann Weller; Robert L Bell; John C Hart; Anne B Need; Jamie H McKinzie; Michael A Statnick; Jeffrey G Suico; David L McKinzie; Sitra Tauscher-Wisniewski; Charles H Mitch; Randall R Stoltz; Conrad J Wong
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.